A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and safety and tolerability of in-hospital initiation of LCZ696 compared to […]

Benefits of Microcor (uCorTM) in Ambulatory Decompensated Heart Failure

Tracking Results of Ablations to Combat AF Registry (Formerly the Maze IV Registry)

A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease with Chronic Bronchitis (SPRAY-CB)

Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization

Jostent GraftMaster Coronary Stent Graft & Delivery System for the treatement of free perforation, defined as free contrast extravasation into the pericardium, in native coronary vessels or saphenous vein bypass grafts

Care Optimization through Patient and Hospital Engagement Clinical Trial for Heart Failure, CONNECT-HF trial

Product Surveillance Registry / Site 10123001

HUMANITARIAN USE DEVICE: The Spiration® Valve System Protocol# H060002

SELECT – Semaglutide effects on cardiovascular outcomes in people with overweight or obesity

Stopping fish oil supplementation prior to total hip replacement a randomized clinical trial